{"url_path":"/sec/evfm/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-023928-index.html","accession_number":"0001493152-26-023928","cik":"0001618835","ticker":"EVFM","issuer_name":"Evofem Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1618835/0001493152-26-023928-index.html","primary_entity_key":"0001618835","primary_entity_name":"Evofem Biosciences, Inc."},"word_count":27,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nRefer\nto [Note 7 - Commitments and Contingencies](#n_007) to the unaudited condensed consolidated financial statements in this Form 10-Q for any required\ndisclosure."}